Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms

Stem Cell Research and Therapy

Volumn 5, Issue 1, 2014, Pages

  Nascimento, Diana Santos ^a   Mosqueira, Diogo ^a   Sousa, Luís Moura ^a,b   Teixeira, Mariana ^c   Filipe, Mariana ^c   Resende, Tatiana Pinho ^a   Araújo, Ana Francisca ^a,d   Valente, Mariana ^a,b   Almeida, Joana ^c   Martins, José Paulo ^c   Santos, Jorge Miguel ^c   Bárcia, Rita Nogueira ^c   Cruz, Pedro ^c   Cruz, Helder ^c   Pinto Do Ó, Perpétua ^a,b  

^a INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c ECBio SA   (Portugal)

^d UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIAPOPTOTIC MECHANISM; APOPTOSIS; ARTICLE; BIOTECHNOLOGY; C57BL 6 MOUSE; CAPILLARY DENSITY; CELL ACTIVATION; CELL ACTIVITY; CELL ASSAY; CELL DIFFERENTIATION; CELL HYPOXIA; CELL STRAIN; CELL STRAIN HL 1; CELL STRAIN SCA 1+; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CORONARY ARTERY LIGATION; CULTURE MEDIUM; FEMALE; GENE ACTIVATION; HEART FUNCTION; HEART INFARCTION; HEART INJURY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; ISCHEMIC PRECONDITIONING; LEFT CORONARY ARTERY; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; THERAPY EFFECT; UMBILICAL CORD MATRIX MESENCHYMAL STROMAL CELL TRANSPLANTATION; UMBILICAL VEIN ENDOTHELIAL CELL;

MURINAE;

EID: 84896713037     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt394     Document Type: Article

References (65)

1. Heart disease and stroke statistics, 2011 update: a report from the American Heart Association. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Circulation 2011 123 18 e209 10.1161/CIR.0b013e3182009701 21160056
2. Scientific Registry of the International Society for Heart and Lung Transplantation: Introduction to the 2010 annual reports. Hertz MI, Aurora P, Christie JD, Dobbels F, Edwards LB, Kirk R, Kucheryavaya AY, Rahmel AO, Rowe AW, Stehlik J, J Heart Lung Transplant 2010 29 1083 1088 10.1016/j.healun.2010.08. 005 20870163
3. Stem-cell therapy for cardiac disease. Segers VF, Lee RT, Nature 2008 451 937 942 10.1038/nature06800 18288183 (Pubitemid 351301749)
4. Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Abdelwahid E, Siminiak T, Guarita-Souza LC, de Carvalho KAT, Gallo P, Shim W, Condorelli G, Curr Cardiol Rev 2011 7 201 212 10.2174/157340311798220502 22758618
5. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O, Exp Hematol 2003 31 890 896 10.1016/S0301- 472X(03)00110-3 14550804 (Pubitemid 37211373)
6. Stromal stem cells: marrow-derived osteogenic precursors. Owen M, Friedenstein AJ, Ciba Found Symp 1988 136 42 60 3068016
7. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM, Br J Haematol 2003 121 368 374 12694261 (Pubitemid 36560606)
8. High efficient isolation and systematic identification of human adipose-derived mesenchymal stem cells. Yang XF, He X, He J, Zhang LH, Su XJ, Dong ZY, Xu YJ, Li Y, Li YL, J Biomed Sci 2011 18 59 10.1186/1423-0127-18-59 21854621
9. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE, Stem Cells 2005 23 220 229 10.1634/stemcells.2004-0166 15671145 (Pubitemid 40239517)
10. Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes. Tsagias N, Koliakos I, Karagiannis V, Eleftheriadou M, Koliakos GG, Transfus Med 2011 21 253 261 10.1111/j.1365-3148. 2011.01076.x 21623971
11. Cardioprotective c-kit + cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK, J Clin Invest 2006 116 1865 1877 10.1172/JCI27019 16823487 (Pubitemid 44033311)
12. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM, Eur Heart J 2008 29 1807 1818 10.1093/eurheartj/ehn220 18523058
13. The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®(R)) in the treatment of inflammatory arthritis. Santos JM, Barcia RN, Simoes SI, Gaspar MM, Calado S, Agua-Doce A, Almeida SC, Almeida J, Filipe M, Teixeira M, Martins JP, Graça L, Cruz MEM, Cruz P, Cruz H, J Transl Med 2013 11 18 10.1186/1479-5876-11-18 23324136
14. Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Psaltis PJ, Zannettino AC, Worthley SG, Gronthos S, Stem Cells 2008 26 2201 2210 10.1634/stemcells.2008-0428 18599808
15. Prepare cells to repair the heart: mesenchymal stem cells for the treatment of heart failure. Ohnishi S, Nagaya N, Am J Nephrol 2007 27 301 307 10.1159/000102000 17460394 (Pubitemid 47164680)
16. Mesenchymal stem cells for cardiac regenerative therapy. Schuleri KH, Boyle AJ, Hare JM, Handb Exp Pharmacol 2007 180 195 218 10.1007/978-3-540-68976- 8-9 17554510
17. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. Wen Z, Zheng S, Zhou C, Wang J, Wang T, J Cell Mol Med 2011 15 1032 1043 10.1111/j.1582-4934.2010.01255.x 21199333
18. Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms. Cashman TJ, Gouon-Evans V, Costa KD, Stem Cell Rev 2013 9 254 265 10.1007/s12015-012-9375-6 22577007
19. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP, Am J Cardiol 2004 94 92 95 10.1016/j.amjcard.2004. 03.034 15219514 (Pubitemid 38813459)
20. Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. Wang CC, Chen CH, Lin WW, Hwang SM, Hsieh PC, Lai PH, Yeh YC, Chang Y, Sung HW, Cardiovasc Res 2008 77 515 524 18006453 (Pubitemid 351197654)
21. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM, Proc Natl Acad Sci U S A 2005 102 11474 11479 10.1073/pnas.0504388102 16061805 (Pubitemid 41153844)
22. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction. Wang YQ, Wang M, Zhang P, Song JJ, Li YP, Hou SH, Huang CX, Chin Med J (Engl) 2008 121 2290 2298 19080335
23. Improvement in cardiac function following transplantation of human umbilical cord matrix-derived mesenchymal cells. Latifpour M, Nematollahi-Mahani SN, Deilamy M, Azimzadeh BS, Eftekhar-Vaghefi SH, Nabipour F, Najafipour H, Nakhaee N, Yaghoubi M, Eftekhar-Vaghefi R, Nabipour F, Najafipour H, Nakhaee N, Yaghoubi M, Eftekhar-Vaghefi R, Salehinejad P, Azizi H, Cardiology 2011 120 9 18 22085866
24. Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function. Otto Beitnes J, Oie E, Shahdadfar A, Karlsen T, Muller RM, Aakhus S, Reinholt FP, Brinchmann JE, Cell Transplant 2012 21 1697 1709 10.3727/096368911X627462 22410280
25. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Tang J, Xie Q, Pan G, Wang J, Wang M, Eur J Cardiothorac Surg 2006 30 353 361 10.1016/j.ejcts.2006.02.070 16829080 (Pubitemid 44051890)
26. Differentiation of bone marrow mesenchymal stem cells induced by myocardial medium under hypoxic conditions. Xie XJ, Wang JA, Cao J, Zhang X, Acta Pharmacol Sin 2006 27 1153 1158 10.1111/j.1745-7254.2006.00436.x 16923335 (Pubitemid 44410995)
27. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Toma C, Pittenger MF, Cahill KC, Byrne BJ, Kessler PD, Circulation 2002 105 93 98 10.1161/hc0102.101442 11772882 (Pubitemid 34049148)
28. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H, Muguruma Y, Tsuboi K, Itabashi Y, Ikeda Y, Ogawa S, Okano H, Hotta T, Ando K, Fukuda K, Blood 2004 104 3581 3587 10.1182/blood-2004-04-1488 15297308 (Pubitemid 39564430)
29. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, Pattany PM, Zambrano JP, Hu Q, McNiece I, Heldman AW, Hare JM, Proc Natl Acad Sci U S A 2009 106 14022 14027 10.1073/pnas.0903201106 19666564
30. Human mesenchymal stromal cells improve scar thickness without enhancing cardiac function in a chronic ischaemic heart failure model. Dayan V, Yannarelli G, Filomeno P, Keating A, Interact Cardiovasc Thorac Surg 2012 14 516 520 10.1093/icvts/ivs048 22361124
31. Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. Ohnishi S, Sumiyoshi H, Kitamura S, Nagaya N, FEBS Lett 2007 581 3961 3966 10.1016/j.febslet.2007.07.028 17662720 (Pubitemid 47212103)
32. Paracrine actions mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Li L, Zhang S, Zhang Y, Yu B, Xu Y, Guan Z, Mol Biol Rep 2009 36 725 731 10.1007/s11033-008- 9235-2 18368514
33. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S, Am J Physiol Heart Circ Physiol 2004 287 2670 H2676 10.1152/ajpheart.01071.2003 15284059 (Pubitemid 39557139)
34. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, Epstein SE, Circulation 2004 109 1543 1549 10.1161/01.CIR.0000124062.31102.57 15023891 (Pubitemid 38420184)
35. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE, Circ Res 2004 94 678 685 10.1161/01.RES.0000118601.37875.AC 14739163 (Pubitemid 38387752)
36. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ, Ann Thorac Surg 2002 73 1919 1926 10.1016/S0003-4975(02)03517-8 12078791 (Pubitemid 34596742)
37. Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. Burdon TJ, Paul A, Noiseux N, Prakash S, Shum-Tim D, Bone Marrow Res 2011 2011 207326 22046556
38. Mesenchymal stem cells as trophic mediators. Caplan AI, Dennis JE, J Cell Biochem 2006 98 1076 1084 10.1002/jcb.20886 16619257 (Pubitemid 44128350)
39. Paracrine mechanisms in adult stem cell signaling and therapy. Gnecchi M, Zhang Z, Ni A, Dzau VJ, Circ Res 2008 103 1204 1219 10.1161/CIRCRESAHA.108. 176826 19028920
40. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Shabbir A, Zisa D, Suzuki G, Lee T, Am J Physiol Heart Circ Physiol 2009 296 1888 H1897 10.1152/ajpheart.00186.2009 19395555
41. Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report. Lopez Y, Lutjemeier B, Seshareddy K, Trevino EM, Hageman KS, Musch TI, Borgarelli M, Weiss ML, Curr Stem Cell Res Ther 2013 8 46 59 10.2174/1574888X11308010007 23270633
42. Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction. Zhang W, Liu XC, Yang L, Zhu DL, Zhang YD, Chen Y, Zhang HY, Coron Artery Dis 2013 24 549 558 10.1097/MCA.0b013e3283640f00 23892469
43. New frontiers in regenerative medicine in cardiology: the potential of Wharton's jelly mesenchymal stem cells. Corrao S, La Rocca G, Lo Iacono M, Zummo G, Gerbino A, Farina F, Anzalone R, Curr Stem Cell Res Ther 2013 8 39 45 10.2174/1574888X11308010006 23278911
44. Isolation method of precursor cells from human umbilical cord. Santos J, Soares R, Martins J, Basto V, Coelho M, Cruz P, Cruz H, In Isolation method of precursor cells from human umbilical cord Portugal: Medinfar, ECBio 2008 [INPI ed., vol. 103843]
45. Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration. Tateishi K, Ashihara E, Takehara N, Nomura T, Honsho S, Nakagami T, Morikawa S, Takahashi T, Ueyama T, Matsubara H, Oh H, J Cell Sci 2007 120 1791 1800 10.1242/jcs.006122 17502484 (Pubitemid 46930417)
46. Directive 2004/23/EC of the European parliament and of the council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. [ http://eur-lex.europa.eu/LexUriServ/LexUriServ.do? uri=OJ:L:2004:102:0048:0058:en:PDF ]
47. Directive 2010/63/EU of the European parliament and of the council of 22 September 2010 on the protection of animals used for scientific purposes. [ http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079: en:PDF ]
48. Guidance document on the recognition, assessment and use of clinical signs as human endpoints for experimental animals used in safety evaluation. [ http://www.oecd-ilibrary.org/docserver/download/9750191e.pdf?expires= 1391474459&id=id&accname=guest&checksum= 9F73864A63C4779BB5ABBBCA6B5CDB5F ]
49. Myocardial ischemia and reperfusion: a murine model. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM, Am J Physiol 1995 269 2147 H2154 8594926
50. MIQuant-semi-automation of infarct size assessment in models of cardiac ischemic injury. Nascimento DS, Valente M, Esteves T, de Pina Mde F, Guedes JG, Freire A, Quelhas P, Pinto-do OP, PLoS One 2011 6 25045 10.1371/journal.pone. 0025045 21980376
51. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, Wang Y, Yeghiazarians Y, Lee RJ, Grossman W, Springer ML, J Appl Physiol 2007 102 2104 2111 10.1152/japplphysiol.00033.2007 17347379 (Pubitemid 47080740)
52. HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Claycomb W, Lanson NJ, Stallworth B, Egeland D, Delcarpio J, Bahinski A, Izzo NJ, Proc Natl Acad Sci U S A 1998 95 2979 2984 10.1073/pnas.95.6.2979 9501201 (Pubitemid 28135840)
53. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Arnaoutova I, Kleinman HK, Nat Protoc 2010 5 628 635 10.1038/nprot.2010.6 20224563
54. Minimal criteria for defining multipotent mesenchymal stromal cells: The International Society for Cellular Therapy position statement. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606 (Pubitemid 44269669)
55. Evidence for cardiomyocyte renewal in humans. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisén J, Science 2009 324 98 102 10.1126/science.1164680 19342590
56. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM, REPAIR-AMI Investigators, N Engl J Med 2006 355 1210 1221 10.1056/NEJMoa060186 16990384 (Pubitemid 44427445)
57. Transcoronary transplantation of progenitor cells after myocardial infarction. Assmus B, Honold J, Schächinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM, N Engl J Med 2006 355 1222 1232 10.1056/NEJMoa051779 16990385 (Pubitemid 44427446)
58. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F, Lancet 2006 367 113 121 10.1016/S0140-6736(05)67861- 0 16413875 (Pubitemid 43077127)
59. Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI). Sürder D, Schwitter D, Moccetti T, Astori G, Rufibach K, Plein S, Lo-Cicero V, Soncin S, Windecker S, Moschovitis A, Wahl A, Erne P, Jamshidi P, Auf der Maur C, Manka R, Soldati G, Bühler I, Wyss C, Landmesser U, Lüscher TF, Corti R, Am Heart J 2010 160 58 64 10.1016/j.ahj.2010.03.039 20598973
60. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K, N Engl J Med 2006 355 1199 1209 10.1056/NEJMoa055706 16990383 (Pubitemid 44427444)
61. G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Fukuhara S, Tomita S, Nakatani T, Ohtsu Y, Ishida M, Yutani C, Kitamura S, Cell Transplant 2004 13 741 748 10.3727/000000004783983486 15690975 (Pubitemid 40280211)
62. Protective paracrine effect of mesenchymal stem cells on cardiomyocytes. Xiang MX, He AN, Wang JA, Gui C, J Zhejiang Univ Sci B 2009 10 619 624 19650201
63. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Nakanishi C, Yamagishi M, Yamahara K, Hagino I, Mori H, Sawa Y, Yagihara T, Kitamura S, Nagaya N, Biochem Biophys Res Commun 2008 374 11 16 10.1016/j.bbrc.2008.06.074 18586003
64. Adult stem cells and biocompatible scaffolds as smart drug delivery tools for cardiac tissue repair. Pagliari S, Romanazzo S, Mosqueira D, Pinto-do OP, Aoyagi T, Forte G, Curr Med Chem 2013 20 3429 3447 10.2174/09298673113209990032 23745554
65. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ, Nat Med 2003 9 1195 1201 10.1038/nm912 12910262 (Pubitemid 37173705)